AI has predicted that a 61-year-old patient at the Silesian Heart Center in Zaberzi will develop worsening heart failure in the near future. The patient said, “I had no idea anything disturbing was going on.” As research shows, the device is able to warn doctors even a month before a patient’s health deteriorates.
AI predicted that a 61-year-old patient from the Department of Cardiology, Congenital Heart Defects and Electrotherapy at the Medical University of Silesia, which operates at the Silesian Heart Center in Zaberzi, will exacerbate heart failure in the near future.
According to the doctors there, it is The first such case in Poland.
The information provided by the HeartLogic algorithm allowed doctors to adjust the drug treatment used, thus – Prevent hospitalization.
An implanted device in a patient Also detect episodes of atrial fibrillation. An examination conducted shortly thereafter at the center confirmed this diagnosis. In the hospital, the patient underwent an excision operation. Today, Mr. Bogusław Dziubek stays at home and feels comfortable.
Information that a 61-year-old patient provided to his PAP shows that he did not have any symptoms that would indicate his health is deteriorating. However, the AI has picked up the disturbing signals.
I had no idea anything disturbing was going on. The doctors phone surprised me a lot. I didn’t feel any discomfort at all, So the information that Disturbing readings were recorded by the remote monitoring center From my implantable device and I need to come for a checkup, it was really shocking to me – Bogusław Dziubek said.
He admits he’s been a little skeptical about the heart monitor.
When I was implanted with a redistributive treatment system and it was made clear that I would be under remote monitoring control, I was calmer, although I have to admit. You have underestimated the possibilities of this layout. I thought it was just a “gimmick.” Meanwhile, when it emerged a month later that the device was “suspected” of having atrial fibrillation and doctors at the hospital confirmed that diagnosis, I was really moved. I’m afraid to think what would happen if we didn’t find out in time that something was wrong – added.
According to Dr. Swaomer Plota of the Cardiovascular Diseases 1st Department of the Silesian Heart Center, in October 2020, Mr. A resynchronization system was implanted with HeartLogic algorithm by Boston Scientific. Since then, the man has been constantly under the care of the implanted device.
Ignorance about atrial fibrillation could cost Mr. Boguslaw his health and even his life.
When a patient first came to us, he had many cardiovascular risk factors. In February of this year, Mr. Bogoslaw’s implanted device sent an alarm with increased values of the “HeartLogic Index”, indicating the risk of no cardiovascular decompensation. We made a decision to change the drug treatment, as a result of which the index value returned to normal Dr. Swaomer Plota explains.
However, this was not the only warning sent from Mr. Bogoslaw’s apparatus.
Just a few days later, we received information about the attacks of atrial fibrillation to the remote monitoring center. The patient has not taken anticoagulant therapy yet, Because it was not previously diagnosed with this type of arrhythmia. The risk of having a stroke was very high for this patient. As part of the teleportation, we immediately prescribed anticoagulant therapy to the patient. Despite the change in drug therapy, arrhythmias continued to recur. This may lead to a loss of cardiac resynchronization function, which may result in cardiovascular failure in the future. Then we decided that Mr Bogoslaw would undergo an atrial fibrillation ablation procedure The doctor continues.
Devices with HeartLogic functions are Intended for transplantation in patients with heart failure. These are pacemakers (ICDs) and defibrillators with resynchronization function (CRT-D). To date, 12 such systems have been implanted in Poland. HeartLogic is a function based on a multisensory analysis of many factors, such as heart tone, respiratory rate, shallowness, heart rate, and patient activity.
HeartLogic is the first function in the world to combine six diagnostic criteria and use it to compute a private index. Scientific studies have confirmed that an index value above 16 may mean the development or worsening of heart failure within up to 30 days. In short, the device can warn us even a month before the patient’s condition deteriorates. Moreover, we know which parameters affected the exceeding of the threshold value of the index – for example, whether an abnormal heart rate, an abnormal chest resistance, or an extremely low patient activity. Thanks to this, we can improve the therapeutic procedures better Dr. Swaomer Plota confirmed.
Experts point out that people with heart failure are among the most difficult groups of heart patients to treat.
This group of patients usually has several additional stressors as well. Taking into account the current epidemiological situation, which, by the way, has been going on for a year, these patients are having difficulties contacting medical services and clinics, but they are also increasingly colliding with overcrowded hospitals. Very important is a parameter that predicts exacerbation and allows you to adjust pharmacotherapy and thus avoid a serious attack of non-cardiovascular decompensation. We are allowed to implement such measures that can help avoid hospitalization for the patient. This is important for the patient, but also for the healthcare system – The head of the Electrophysiology and Cardiac Simulation Laboratory at the Silesian Heart Center in Zaberzi explains, Prof. Oscar Kowalski.
Doctors from the Silesian Cardiac Center in Zaberzi confirm that solutions like HeartLogic only work optimally when accompanied by appropriate telemedicine facilities.
Thanks to the remote monitoring of transmissions, the violations recorded by the device with the HeartLogic function were immediately transferred to the remote monitoring center, and our employees were able to immediately respond to the alert – Head of Department of Cardiology, Congenital Heart Defects and Electrotherapy, Medical University of Silesia in Zaberzi, Prof. Zbigniew Kalaros.